Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation

Published Jun 4, 2020

Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation

NOW
PLAYING
The 'Right to Try' Act Explained: Cancer Survivor at the RNC Says She’s Alive Thanks to It
NOW
PLAYING
Nearly 40% of Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Cancer Patients
NOW
PLAYING
What the New Ovarian Cancer Drug Combo Approval Means for Patients
NOW
PLAYING
Ovarian Cancer Clinical Trials
NOW
PLAYING
HER2-Positive Metastatic Breast Cancer Treatment Options
NOW
PLAYING
Cancer Doesn't Mean the End—Senator Harry Reid Talks To SurvivorNet About the Experimental New Therapy That Saved His Life
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.